Skip to main content

Site notifications

We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

Sub menu

News and events
Contact us
About us

Search

Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

You are here

Home
Resources and guidance
Sponsors

Juno Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (261)
Cancellation by sponsor (83)
Prescription medicine registration (28)
Section 14, TGO91 consent (6)
Australian public assessment report (AusPar) (1)
Prescription medicine decision summary (1)

Date

2026 (3)
2025 (23)
2024 (13)
2023 (18)
2022 (35)
2021 (68)
2020 (45)
2019 (51)
2018 (18)
2017 (14)
2016 (17)
2015 (14)
2014 (7)
2013 (8)
2012 (12)
2011 (5)
2010 (1)
2009 (2)
2007 (1)
2006 (4)
2003 (7)
2000 (1)
1999 (2)
1998 (1)
1996 (3)
1994 (2)
1991 (5)

Search

Sponsor content

380 result(s) found, displaying 201 to 210

LANPRO latanoprost 50 micrograms/mL eye drop solution bottle Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
BICALIDE bicalutamide 50mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
NEZOLID linezolid 600 mg/300 mL injection solution bag Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
ASTZOL anastrozole 1 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
CAPECITABINE AN capecitabine 500 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
CAPECITABINE AN capecitabine 150 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
LETROZOLE AN letrozole 2.5 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

30 June 2021

Cancellation by sponsor

Requested by Juno Pharmaceuticals Pty Ltd
DAPTOMYCIN JUNO daptomycin 350 mg powder for injection vial (300039)

23 April 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DAPTOMYCIN JUNO daptomycin 350 mg powder for injection vial.
DAPTOMYCIN JUNO daptomycin 500 mg powder for injection vial (300034)

23 April 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for DAPTOMYCIN JUNO daptomycin 500 mg powder for injection vial.
LENALEX, LENALIDE, LENALIDOMIDE JUNO (Juno Pharmaceuticals Pty Ltd)

22 June 2021

Prescription medicine registration

Active ingredients: lenalidomide.

Pages

First page
Previous page
…
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

© Commonwealth of Australia